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Area-Based Differentials in Childhood Cancer
Incidence in Australia, 1996–2006
Danny R. Youlden, BSc,1* Peter D. Baade, PhD,1,2 Patricia C. Valery, MD, MPH, PhD,3,4
Timothy E. Hassall, MBBS, FRACP,5 Leisa J. Ward,1 Adele C. Green, MBBS, PhD, MSc,3 and
Joanne F. Aitken, BSc, SM, PhD1,6
Background. International studies examining the association
between the incidence of childhood cancer and characteristics of
the area in which the patient lives have generally reported inconsistent patterns. Area-based differentials in childhood cancer
throughout Australia have not been previously published at a
national level. Procedure. Population-based information from the
Australian Paediatric Cancer Registry was used to identify all children aged 0- to 14-years old diagnosed with invasive cancer or
intracranial and intraspinal tumors of benign or uncertain behavior
between 1996 and 2006. Age-standardized incidence rates per
million children per year and the corresponding incidence rate
ratios were calculated, categorized by remoteness of residence
and an area-based index of socioeconomic disadvantage. Results
were also stratiﬁed by the most common types of childhood cancer.

Key words:

Results. There was a signiﬁcant, decreasing gradient in the incidence of childhood cancer as remoteness of residence increased.
Children living in remote or very remote areas were 21% less likely
to be diagnosed with cancer compared to children in major cities,
mainly due to differences in the incidence of leukemias and lymphomas. This differential was no longer signiﬁcant when only nonIndigenous children were considered. No clear relationship was
found between incidence and socioeconomic status (SES) in contrast to similar earlier studies. Conclusions. The ﬁndings by remoteness of residence are consistent with the lower incidence rates of
cancer that are typically associated with Indigenous Australians.
There is also a suggestion that the etiological factors associated with
childhood leukemia and SES may have altered over time. Pediatr
Blood Cancer 2012;58:390–394. ß 2011 Wiley Periodicals, Inc.
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INTRODUCTION

METHODS

Although cancer among children is relatively rare, the
consequences are far-reaching. In particular, cancer is the most
common cause of disease-related death among children aged 1- to
14-years old in both Australia [1] and other high income countries
[2]. Beyond the loss of young lives, the burden of childhood
cancer extends to the long-term adverse health effects that may
be experienced by survivors [3,4], as well as signiﬁcant psychosocial and ﬁnancial imposts on their families [5,6].
The causes of childhood cancer are largely unclear [7]. A
better understanding of how incidence differs depending on the
characteristics of the area where a child lives may help to unravel
some of the etiological factors that contribute to the development
of cancer. Studies examining this issue have generally been inconclusive when considered collectively [8–15]. A review of the
potential link between childhood leukemia and socioeconomic
status (SES) [8] found the association varied depending on the
time that the study was conducted, the study design (area-based
vs. case–control) and the measure used to determine SES. The
authors identiﬁed the need for contemporary analyses using areabased data to establish whether the relationship between higher
SES and the increased incidence of childhood leukemia that was
previously reported in some countries was still present [8].
A study conducted in the early 1980s in Queensland (Australia) [16] reported a signiﬁcant correlation between area-level
SES and incidence rates of acute lymphoblastic leukemia among
children. However, a similar relationship with SES was not
present for other types of childhood cancer [16]. Building on this
work, we have utilized the latest available data from the Australian Paediatric Cancer Registry (APCR) to investigate at a national
level the association between different types of childhood cancer
and an area-based measure of SES. In addition, we also examined
whether there was a link between remoteness of residence and the
incidence of childhood cancer.

The APCR is one of only a few national, population-based
childhood cancer registries in the world [17]. Details on every
case of childhood cancer (aged 0–14 years at diagnosis) are
collected with the assistance of each State and Territory cancer
registry and all major pediatric hospitals in Australia. The
diagnostic group for each child was allocated according to
the third edition of the International Classiﬁcation of Childhood
Cancers (ICCC-3), which covers all invasive cancers and
intracranial and intraspinal tumors of benign or uncertain
behavior [18].
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Almost all (99.7%) eligible cases of childhood cancer in the
APCR occurring during the period 1996–2006 were able to
be assigned to remoteness and SES categories based on address
at diagnosis. The unmatched cases (n ¼ 18) were removed
from the analysis. Population counts by sex, age group, year,
and locality were obtained from the Australian Bureau of
Statistics [19].
Four categories of remoteness were speciﬁed based on
the Australian Standard Geographical Classiﬁcation (ASGC)
Remoteness Areas [20]: ‘‘Major cities,’’ ‘‘Inner regional,’’ ‘‘Outer
regional,’’ and ‘‘Remote/very remote.’’ The ASGC remoteness
classiﬁcation is a purely geographic measure without any direct
consideration of SES. Broadly speaking, inner regional areas are
those on the fringes of major cities where residents may experience minor restrictions in access to some services. Outer regional
areas are generally of a more rural nature, while people in remote/
very remote localities are living hundreds, if not thousands, of
kilometres away from major cities and the services that they
provide.
Road distance measurements to the nearest service centers
were used to determine the remoteness category for each locality.
Service centers were split into ﬁve groupings based on population
size, ranging from 1,000 to 4,999 residents (Category E service
center) up to >250,000 residents (Category A service center). The
ﬁve distance measurements for an individual locality were each
standardized to a ratio by dividing by the national mean for the
corresponding service center category and then added together
to give a total. More remote localities were represented by a
higher score.
In the absence of individual indicators of SES, an areabased measure called the Index of Relative Socioeconomic Disadvantage (IRSD) [21] was used. Derived from national census
information, the IRSD takes into account factors including the
percentage of people in a locality with low income, low educational attainment, and who are either unemployed or employed
in relatively unskilled occupations. Localities were categorized
as ‘‘Least disadvantaged’’ (quintile 5 for IRSD), ‘‘Middle SES’’
(quintiles 2–4), or ‘‘Most disadvantaged’’ (quintile 1).
Incidence rates directly age-standardized to the 2000 World
Standard Population [22] were calculated for all cancers combined and for the three largest diagnostic groups [leukemias,
tumors of the central nervous system (CNS), and lymphomas].
The remaining cancer types were aggregated into a group labeled
‘‘Other solid tumors’’ to enable sufﬁcient numbers for analysis.
Poisson regression was used to estimate incidence rate ratios
and 95% conﬁdence intervals, with the selected baseline
categories for remoteness and SES being those with the highest
number of cases, that is, ‘‘Major cities’’ and ‘‘Middle SES’’,
respectively. Models included sex, age group at diagnosis and
either remoteness or SES, all speciﬁed as categorical variables.
The signiﬁcance of the gradient across the variables of interest
was investigated by rerunning the models and ﬁtting remoteness
or SES as continuous variables. An interaction term for remoteness and SES was included in a separate model, with the remoteness categories ‘‘Outer regional’’ and ‘‘Remote/very remote’’
aggregated to allow sufﬁcient numbers for the model to converge.
For each model, the response variable was the number of childhood cancer cases in each strata offset by the log of the corresponding population, while goodness of ﬁt was assessed using a
chi-squared test.
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Indigenous children (those who identify as being of Australian
Aboriginal or Torres Strait Islander origin) are estimated to comprise just over 2% of the population aged under 15-years old in
major cities compared to approximately 38% [correction made
here after initial publication] in remote/very remote parts of Australia [23]. Maintenance of traditional culture is more common in
isolated areas [24]. The health status of Indigenous children also
differs to that of non-Indigenous children across a range of
indicators [24]. In order to assess the impact that these factors might
have on the results of our investigation, the regression analysis by
remoteness was repeated for non-Indigenous children only.
All analyses were conducted using STATA/SE version 11.1 for
Windows. Approval for this work was obtained from the ethics
committees of the Queensland Institute of Medical Research, the
University of Queensland, the cancer registries in all Australian
States and Territories, and all hospitals that contributed to the data
collection.

RESULTS
A total of 6,757 Australian children who were eligible for
inclusion in the study were diagnosed with cancer during the
study period. Over half of these children were male (54%), and
the distribution of age at diagnosis was 46% aged 0–4 years, 25%
aged 5–9 years, and 29% aged 10–14 years. Approximately, twothirds of cases had leukemias (33%), tumors of the CNS (23%),
or lymphomas (10%).
The age-standardized incidence rates of all childhood cancer
combined varied from 159.9 cases per million children per year
in major cities to 126.5 cases per million children per year in
remote/very remote areas. There was a signiﬁcant, decreasing
gradient (Pgrad ¼ 0.002) in the incidence rate ratios as remoteness
of residence increased, with children from remote or very remote
areas being 21% less likely to be diagnosed with cancer compared
to those in major cities (Table I). Signiﬁcant gradients by remoteness of residence were also found within the diagnostic groups of
leukemias and lymphomas. There was no discernable pattern in
the incidence rate ratios by remoteness for either tumors of the
CNS or other solid tumors.
The association between remoteness and childhood cancers
appeared to be mainly driven by the lower incidence reported
among children in remote/very remote areas. When the relevant
models were rerun only including incidence and population data
for children who were identiﬁed as being non-Indigenous
(n ¼ 5,972), the resulting gradients for the adjusted incidence
rate ratios by remoteness of residence for all childhood cancers
combined (Pgrad ¼ 0.333), leukemias (Pgrad ¼ 0.536), and lymphomas (Pgrad ¼ 0.081) were no longer signiﬁcant.
As shown in Table II, the overall incidence rate of childhood
cancer was slightly higher among children in the least socioeconomically disadvantaged areas (162.0 cases per million children
per year) compared to those in the most disadvantaged areas
(150.7 cases per million children per year). However, the gradient
for the adjusted incidence rate ratios was not statistically signiﬁcant (Pgrad ¼ 0.081). A similar pattern across the SES categories
was observed for the adjusted incidence rate ratios among children with leukemias, lymphomas, and tumors of the CNS, but the
gradient was non-signiﬁcant within each of these diagnostic
groups. The analysis was repeated for the diagnostic subgroup

TABLE I. Childhood Cancer Incidence by Diagnostic Group and Remoteness, Australia, 1996–2006
Diagnostic group,
Remoteness category
All cancers (n ¼ 6,757)
Major cities
Inner regional
Outer regional
Remote/very remote
Leukemias (n ¼ 2,259)
Major cities
Inner regional
Outer regional
Remote/very remote
Lymphomas (n ¼ 675)
Major cities
Inner regional
Outer regional
Remote/very remote
Tumors of the CNS (n ¼ 1,521)c
Major cities
Inner regional
Outer regional
Remote/very remote
Other solid tumors (n ¼ 2,302)c,d
Major cities
Inner regional
Outer regional
Remote/very remote

Number
of cases

ASIR per million children
per year (95% CI)a

Adjusted incidence
rate ratio (95% CI)b

4,038
1,671
831
217

159.9 (155.1–165.0)
151.7 (144.5–159.2)
153.3 (143.0–164.1)
126.5 (110.2–144.6)

1.00
0.95 (0.90–1.00)
0.96 (0.89–1.03)
0.79 (0.69–0.91)

1,365
554
269
71

54.2 (51.4–57.2)
50.8 (46.6–55.2)
50.0 (44.2–56.4)
41.1 (32.1–51.8)

1.00
0.94 (0.85–1.03)
0.92 (0.81–1.05)
0.76 (0.60–0.96)

416
167
72
20

16.3 (14.8–18.0)
14.5 (12.4–16.9)
12.9 (10.1–16.3)
11.8 (7.2–18.3)

1.00
0.89 (0.74–1.06)
0.78 (0.61–1.01)
0.72 (0.46–1.13)

895
394
187
45

35.4 (33.1–37.8)
35.7 (32.3–39.4)
34.2 (29.5–39.5)
26.0 (19.0–34.9)

1.00
1.00 (0.89–1.13)
0.97 (0.83–1.13)
0.74 (0.55–1.00)

1,362
556
303
81

54.0 (51.2–56.9)
50.7 (46.5–55.1)
56.2 (50.0–62.9)
47.6 (37.8–59.3)

1.00
0.94 (0.85–1.04)
1.04 (0.92–1.18)
0.88 (0.70–1.10)

Pgrad
0.002

0.015

0.016

0.168

0.560

ASIR, age-standardized incidence rate; CI, conﬁdence interval; CNS, central nervous system; aIncidence rates age-standardized to the 2000
World Standard Population; bIncidence rate ratio adjusted for sex and age group at diagnosis; cDiagnostic group includes intracranial/intraspinal
tumors of benign or uncertain behavior; dThe diagnostic group ‘‘Other solid tumors’’ includes neuroblastoma, retinoblastoma, renal tumors,
hepatic tumors, malignant bone tumors, soft tissue sarcomas, germ cell tumors, other malignant epithelial neoplasms and melanomas, and other
and unspeciﬁed malignant neoplasms.

TABLE II. Childhood Cancer Incidence by Diagnostic Group and Socioeconomic Status, Australia, 1996–2006
Diagnostic group,
SES category
All cancers (n ¼ 6,756)
Least disadvantaged
Middle SES
Most disadvantaged
Leukemias (n ¼ 2,259)
Least disadvantaged
Middle SES
Most disadvantaged
Lymphomas (n ¼ 675)
Least disadvantaged
Middle SES
Most disadvantaged
Tumors of the CNS (n ¼ 1,521)c
Least disadvantaged
Middle SES
Most disadvantaged
Other solid tumors (n ¼ 2,301)c,d
Least disadvantaged
Middle SES
Most disadvantaged

Number
of cases

ASIR per million children
per year (95% CI)a

Adjusted incidence
rate ratio (95% CI)b

1,370
4,396
990

162.0 (153.5–170.8)
155.0 (150.4–159.6)
150.7 (141.4–160.4)

1.04 (0.98–1.11)
1.00
0.97 (0.91–1.04)

463
1,465
331

55.3 (50.4–60.6)
51.9 (49.3–54.6)
50.4 (45.1–56.1)

1.06 (0.96–1.18)
1.00
0.97 (0.86–1.09)

141
441
93

16.1 (13.5–19.0)
15.2 (13.9–16.7)
14.1 (11.3–17.2)

1.06 (0.87–1.28)
1.00
0.92 (0.74–1.15)

317
994
210

37.2 (33.3–41.6)
35.0 (32.8–37.2)
31.9 (27.7–36.5)

1.07 (0.94–1.21)
1.00
0.91 (0.79–1.06)

449
1,496
356

53.4 (48.5–58.6)
52.9 (50.2–55.6)
54.3 (48.8–60.3)

1.00 (0.90–1.12)
1.00
1.03 (0.91–1.15)

Pgrad
0.081

0.190

0.315

0.079

0.776

SES, socioeconomic status; ASIR, age-standardized incidence rate; CI, conﬁdence interval; CNS, central nervous system; aIncidence rates agestandardized to the 2000 World Standard Population; bIncidence rate ratio adjusted for sex and age group at diagnosis; cDiagnostic group
includes intracranial/ intraspinal tumors of benign or uncertain behavior; dThe diagnostic group ‘‘Other solid tumors’’ includes neuroblastoma,
retinoblastoma, renal tumors, hepatic tumors, malignant bone tumors, soft tissue sarcomas, germ cell tumors, other malignant epithelial
neoplasms and melanomas, and other and unspeciﬁed malignant neoplasms.
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of lymphoid leukemias in an attempt to verify the results from the
previous study in Queensland [16], but the association with SES
also failed to reach statistical signiﬁcance (Pgrad ¼ 0.146). Applying a different index of SES that was based on education and
occupation only (as suggested by Poole et al. [8]) yielded comparable, insigniﬁcant gradients in childhood cancer incidence
(results not shown).
There was no statistically signiﬁcant evidence of interaction
between remoteness and SES for all childhood cancers combined
(P ¼ 0.185) or for any of the diagnostic groupings (leukemias:
P ¼ 0.632; lymphomas: P ¼ 0.816; tumors of the CNS: P ¼
0.398; other solid tumors: P ¼ 0.340).

DISCUSSION
This is the ﬁrst time that patterns of childhood cancer
incidence by either remoteness or area-based SES have been
investigated at a national level for Australia. We found that children living in more urban areas had higher rates of cancer overall,
particularly for leukemias and lymphomas. In contrast, there was
little evidence of any differentials related to area-level measures
of SES.
Published data on childhood cancer incidence by remoteness
of residence are generally scarce, with the exception of a series
of articles on the geographical distribution of childhood cancer in
North-West England [12–14]. McNally et al. [12] reported higher
incidence of acute lymphoblastic leukemia in areas with higher
population density. No corresponding association was found for
lymphomas, which also exhibited a signiﬁcant gradient across the
remoteness categories in our study. Consistent with our results,
they reported no clear relationship with rurality or population
density for tumors of the CNS [14]. Another study, which primarily examined an infectious mechanism (known as population
mixing) for acute lymphoblastic leukemia in England and Wales,
failed to establish an association between the incidence of ALL
and population density [15].
Some of the variation regarding the impact of remoteness on
childhood cancer incidence may be due to inherent geographic
differences between Australia and the United Kingdom. In Australia, there are often much longer traveling distances to larger
towns and cities for people living in a rural or remote area, with
considerable implications in terms of time, cost, and access to
services. Furthermore, in the United Kingdom rural areas tend to
be associated with higher SES [25], while the converse is generally true for Australia [26].
A higher incidence rate of lymphoma in major cities throughout Australia has been previously reported among all persons,
including adults and children [27]. However, as opposed to the
ﬁndings for childhood leukemia, no signiﬁcant differences were
reported in the incidence rates across the various remoteness
categories for all leukemia patients throughout Australia [27].
The factors which contribute to the excess of lymphoma in more
urbanised areas irrespective of age at diagnosis are yet to be
identiﬁed.
One potential reason for the signiﬁcant differential in all childhood cancers by remoteness is that remote/very remote areas
typically contain a relatively high proportion of Indigenous residents, and it is known that cancer incidence tends to be lower
within this segment of the Australian adult population [28]. This
Pediatr Blood Cancer DOI 10.1002/pbc
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concept was supported by a reanalysis of the data for non-Indigenous children only, with the modiﬁed gradient by remoteness of
residence no longer signiﬁcant. Even if this proves to be a plausible explanation for some of the observed variation, it is currently
not known why cancer incidence would be lower among Indigenous children.
Another possible consideration involves the difﬁculties
presented by the distances to specialized health care. Families
of cancer patients who live in very isolated areas of
Australia are confronted with major challenges regarding
access to diagnostic, treatment, and support services [29–31].
This could result in some level of underdiagnosis of cancer
among children from remote communities, although it should
be noted that there is no speciﬁc evidence to support this
hypothesis.
Area-based analyses from the 1980s or earlier from countries
including Australia, the United States, and the United Kingdom
described a fairly consistent relationship between higher SES
and an increased incidence of childhood leukemia [8]. This
effect seems to have diminished more recently [9] as supported
by our results, adding further weight to the theory that there
may have been a shift in the underlying etiology of childhood
leukemia over time [8]. No other signiﬁcant trends in the incidence of other types of childhood cancer were evident by SES in
either Australia or a similar analysis conducted in Canada, except
for a lower rate of carcinomas in the poorest quintile of the
Canadian population which may have been caused by random
variation [10].
One of the strengths of this study is the complete coverage of
children with cancer in Australia through the APCR, combined
with high-quality data [17]. The population-based design prevents
the introduction of selection bias that can occur with clinical
trials. While information was not available from the APCR on
personal indicators of SES for the parents of children with cancer,
other authors have suggested that the use of area-based data as a
proxy for individual SES may be more meaningful when considering the health of children [9]. We were unable to analyze data
for each of the ICCC-3 diagnostic groups separately, apart from
the three most common types of childhood cancer, due to the
relatively small number of cases in some cells, particularly
remote/very remote areas. This potentially could have prevented
us from discovering speciﬁc area-based associations for other
diagnostic groups that were not apparent after the data were
combined.
In conclusion, our ﬁndings suggest that in Australia there is a
signiﬁcant gradient in the incidence of childhood cancer by
remoteness of residence, particularly for leukemias and lymphomas. The incidence of these childhood cancers is higher in urban
than rural areas, in contrast to the poorer health that is typically
experienced in regional and remote areas of Australia [27]. It
appears that much of this differential is due to the Indigenous
population in remote parts of the country. Future work is planned
to examine childhood cancer incidence by Indigenous status in
detail. Consistent with recent international case–control studies,
our study supports the hypothesis that the relationship between
area-based measures of SES and childhood cancer incidence
has also weakened. Further research is needed to determine
whether, in an environment of lower incidence, survival outcomes
for rural childhood cancer patients are equitable with their urban
counterparts.
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